cupure logo
trumpepsteintrumpspolicewomanshowkilleddonaldcrashreveals

Cancer drug snub wipes £3bn off GSK value

Cancer drug snub wipes £3bn off GSK value
GSK was trying to revive a product pulled from US markets in 2022. Its shares fell 4.6 per cent, or 65p, to 1348p.

Comments

Similar News

Breaking news